Back
Iron Mountain Vs. Spyre Therapeutics Industry Stock Comparison
Buy
68
IRM
Iron Mountain
Last Price:
115.36
Seasonality Move:
4.5%
Buy
53
SYRE
Spyre Therapeutics
Last Price:
30.15
Seasonality Move:
-4.84%
Buy
68
Iron Mountain (IRM)
is a Buy
Is Iron Mountain a Buy, Sell or Hold?
- The current Iron Mountain [IRM] share price is $114.13. The Score for IRM is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- IRM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Spyre Therapeutics (SYRE)
is a Buy
Is Spyre Therapeutics a Buy, Sell or Hold?
- The current Spyre Therapeutics [SYRE] share price is $30.39. The Score for SYRE is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- SYRE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IRM Stock Price Chart
What is Iron Mountain's stock price today?
-
The Iron Mountain share price today is $114.13
The current trend is moderately bullish and IRM is experiencing slight selling pressure.
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $30.39
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SYRE is experiencing buying pressure, which is a positive indicator for future bullish movement.
IRM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.46 | Buy |
| Relative Strength Index (14 RSI): | 56.21 | Buy |
| Chaikin Money Flow: | -705514 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (110.13 - 115.57) | Buy |
| Bollinger Bands (100): | (82.64 - 108.92) | Buy |
SYRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.59 | Buy |
| Relative Strength Index (14 RSI): | 60.55 | Buy |
| Chaikin Money Flow: | 253932 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.52 - 29.08) | Buy |
| Bollinger Bands (100): | (25.58 - 34.28) | Buy |
IRM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 115.83 | Sell |
| 20-day SMA: | 113.66 | Buy |
| 50-day SMA: | 107.51 | Buy |
| 200-day SMA: | 84.12 | Buy |
| 8-day EMA: | 115.18 | Sell |
| 20-day EMA: | 113.27 | Buy |
| 50-day EMA: | 107.27 | Buy |
| 200-day EMA: | 87.89 | Buy |
SYRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.97 | Buy |
| 20-day SMA: | 28.07 | Buy |
| 50-day SMA: | 27.96 | Buy |
| 200-day SMA: | 29.09 | Buy |
| 8-day EMA: | 29.06 | Buy |
| 20-day EMA: | 28.34 | Buy |
| 50-day EMA: | 28.24 | Buy |
| 200-day EMA: | 27.28 | Buy |
Iron Mountain Earnings Growth & IRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.05 per share, an increase this year of $0.17 per share, and an increase next year of $0.25 per share.
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.24 per share, an increase this year of $9.51 per share, and an increase next year of $0.02 per share.
Iron Mountain Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Spyre Therapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||